Overview
Study information
| Network: | VaxGen |
| Grant Affiliation: | NA |
| Strategy: | Protein and peptide vaccines |
| Study Type: | Phase III |
| Species: | Human |
| Stage: | Primary Analysis Complete |
| Study Start Date: | 1998-06-15 |
| Study Made Public: | NA |
Title
A Phase III trial to determine the efficacy of bivalent AIDSVAX B/B vaccine in adults at risk of sexually transmitted HIV-1 infection in North America
Description
VAX 004 is a Phase III clinical trial to determine the effectiveness of an HIV vaccine in HIV-negative adults in North America who are at risk of HIV Infection.
Sign in to see full information about this study and to download study data.
Products
AIDSVAX B/B AlumIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.